Draper Triangle Ventures

Locomation, Inc. is a technology company based in Pittsburgh, Pennsylvania, specializing in the development of autonomous driving solutions for the trucking industry. Established in 2016, Locomation focuses on enhancing trucking safety and efficiency through its Autonomous Relay Convoy (ARC) system, which combines artificial intelligence with driver augmentation. This innovative approach allows one truck to autonomously follow a lead truck operated by a human driver, facilitating safer and more cost-effective transportation. The company aims to reduce truck-involved accidents and improve operational efficiency for trucking companies by leveraging advanced AI-driven systems for both commercial and defense applications.

Ikos Holdings Co. operates an online platform that connects landlords and renters, streamlining the rental experience for both parties. Founded in 2017 and based in Pittsburgh, Pennsylvania, the company offers a flexible on-demand leasing service for investors while utilizing data analysis to guide client investments. By simplifying the rental process, Ikos helps landlords and renters make informed decisions, fostering transparency and adaptability in their interactions. The platform aims to enhance the way individuals engage with rental properties, ultimately benefiting the real estate market.

Babel Health, LLC is a developer of a cloud-based risk adjustment platform aimed at government-sponsored health programs. Founded in 2014 and based in Pittsburgh, Pennsylvania, the company offers a Software-as-a-Service solution that enables users to manage compliant submissions across various systems, including encounter data processing and risk adjustment payment systems. Babel Health's platform features a user-friendly Extract, Transform, and Load (ETL) tool specifically designed for processing healthcare data, allowing mid-size health plans to effectively navigate and integrate new technology in a cost-efficient manner. The company's primary product is a fully operational application for Encounter Data Processing System submissions, which helps organizations streamline complex processes and enhance data management capabilities.

Locomation, Inc. is a technology company based in Pittsburgh, Pennsylvania, specializing in the development of autonomous driving solutions for the trucking industry. Established in 2016, Locomation focuses on enhancing trucking safety and efficiency through its Autonomous Relay Convoy (ARC) system, which combines artificial intelligence with driver augmentation. This innovative approach allows one truck to autonomously follow a lead truck operated by a human driver, facilitating safer and more cost-effective transportation. The company aims to reduce truck-involved accidents and improve operational efficiency for trucking companies by leveraging advanced AI-driven systems for both commercial and defense applications.

Containership, Inc. is a technology company based in Pittsburgh, Pennsylvania, that specializes in cloud-based solutions for container management. Established in 2015, it offers a Platform-as-a-Service that enables users to automate, scale, and deploy applications across various cloud environments and data centers. The company's open-source Docker hosting platform facilitates application deployment, cluster scheduling, and service discovery. Additionally, Containership provides a hosted service that includes features such as automated provisioning, marketplace integrations, load balancing, and cluster snapshots. This comprehensive approach allows businesses to efficiently manage their containerized applications and easily transition between different cloud providers.

RE2 Robotics, based in Pittsburgh, PA, is a Carnegie Mellon University spin-off founded in 2001 by Jorgen Pedersen. The company specializes in developing intelligent mobile manipulation systems designed for various industries, including defense, aviation, construction, energy, and healthcare. RE2 Robotics creates manipulator arms that offer human-like performance and intuitive interfaces, allowing users to remotely perform tasks in challenging environments, whether on the ground, in the air, or underwater. With a significant focus on military applications, over 400 of its robotic arms have been deployed for explosive ordnance disposal missions, enhancing safety and efficiency while reducing operational costs. The company's innovative technologies aim to save lives and improve the quality of life through advanced robotics.

Rhiza, Inc. develops an online marketing analytics platform that transforms big data into actionable insights for marketers and sales professionals. Founded in 2008 and based in Pittsburgh, Pennsylvania, with an additional office in Seattle, the company provides tools that empower media publishers and advertisers to enhance their marketing strategies. Rhiza's software enables users to visualize, analyze, and share information from diverse data sets, thereby facilitating better understanding of audiences, content, and advertising effectiveness. The platform is utilized by leading media organizations, allowing them to optimize media buys, track campaign performance, and devise new marketing plans. As of 2017, Rhiza operates as a subsidiary of Nielsen Holdings plc.

BodyMedia, founded in 1999 and based in Pittsburgh, PA, specializes in wearable body monitoring devices that gather physiological data to enhance health, wellness, and fitness. The company offers a range of continuous on-body monitors that utilize proprietary technology validated for clinical accuracy. These devices serve both consumers and health professionals, facilitating behavioral adjustments aimed at weight management and active living—critical factors in addressing serious health issues. BodyMedia's products include a calorie management system that tracks calories burned against those consumed, alongside body monitoring systems that record various physiological metrics analyzed through its SenseWear software. The company has contributed significantly to health research, participating in over 100 clinical studies related to obesity, diabetes, and other medical conditions, thereby creating one of the largest databases of human physiological information.

Helomics Corporation, established in 1995 and headquartered in Pittsburgh, Pennsylvania, is a personalized healthcare company specializing in cancer care. It develops and delivers a portfolio of products to aid physicians and patients in making informed clinical decisions. Helomics' core technology, the Precision Cellular Analytical Platform, collects and analyzes cell cycle and proliferation data over an extended period. Key products include ChemoFx, BioSpeciFx, GeneFx Colon, and GeneFx Lung, which help physicians select effective treatments and understand potential drug responses or prognosis. The company also offers tumor profiling services, contract research and development, and biorepository and banking services. Helomics operates as a contract research organization (CRO), providing oncology insights for six primary cancers and using artificial intelligence and its D-CHIP platform to create personalized oncology roadmaps. It serves the pharmaceutical, diagnostic, biotechnology, and research industries, aiming to improve patient outcomes through personalized treatments and diagnostics.

BitArmor Systems was a security software company located in Pittsburgh, Pennsylvania, specializing in information-centric data security solutions. The company developed an integrated encryption technology designed to safeguard data across various devices, including laptops, desktops, USB drives, and email attachments. Its offerings included cloud-based encryption solutions for mid-market businesses, focusing on file and disk encryption to protect sensitive information stored in multiple formats like CDs, DVDs, storage servers, and tapes. BitArmor's innovative approach to data security garnered attention, ultimately leading to its acquisition by Trustwave Holdings, Inc.

Helomics Corporation, established in 1995 and headquartered in Pittsburgh, Pennsylvania, is a personalized healthcare company specializing in cancer care. It develops and delivers a portfolio of products to aid physicians and patients in making informed clinical decisions. Helomics' core technology, the Precision Cellular Analytical Platform, collects and analyzes cell cycle and proliferation data over an extended period. Key products include ChemoFx, BioSpeciFx, GeneFx Colon, and GeneFx Lung, which help physicians select effective treatments and understand potential drug responses or prognosis. The company also offers tumor profiling services, contract research and development, and biorepository and banking services. Helomics operates as a contract research organization (CRO), providing oncology insights for six primary cancers and using artificial intelligence and its D-CHIP platform to create personalized oncology roadmaps. It serves the pharmaceutical, diagnostic, biotechnology, and research industries, aiming to improve patient outcomes through personalized treatments and diagnostics.

BitArmor Systems was a security software company located in Pittsburgh, Pennsylvania, specializing in information-centric data security solutions. The company developed an integrated encryption technology designed to safeguard data across various devices, including laptops, desktops, USB drives, and email attachments. Its offerings included cloud-based encryption solutions for mid-market businesses, focusing on file and disk encryption to protect sensitive information stored in multiple formats like CDs, DVDs, storage servers, and tapes. BitArmor's innovative approach to data security garnered attention, ultimately leading to its acquisition by Trustwave Holdings, Inc.

Helomics Corporation, established in 1995 and headquartered in Pittsburgh, Pennsylvania, is a personalized healthcare company specializing in cancer care. It develops and delivers a portfolio of products to aid physicians and patients in making informed clinical decisions. Helomics' core technology, the Precision Cellular Analytical Platform, collects and analyzes cell cycle and proliferation data over an extended period. Key products include ChemoFx, BioSpeciFx, GeneFx Colon, and GeneFx Lung, which help physicians select effective treatments and understand potential drug responses or prognosis. The company also offers tumor profiling services, contract research and development, and biorepository and banking services. Helomics operates as a contract research organization (CRO), providing oncology insights for six primary cancers and using artificial intelligence and its D-CHIP platform to create personalized oncology roadmaps. It serves the pharmaceutical, diagnostic, biotechnology, and research industries, aiming to improve patient outcomes through personalized treatments and diagnostics.

Aethon Inc. develops autonomous mobile delivery robot systems that enhance logistics within hospitals by transporting medications, meals, and materials. The company's flagship product, TUG, is an automated robotic delivery system that efficiently manages both scheduled and on-demand deliveries across various hospital departments. TUG employs RFID technology for effective asset tracking and can also handle trash removal. Aethon offers additional software solutions such as MedEx, which maintains chain-of-custody control for medication deliveries, and MedSafe, which oversees order preparation and courier tracking. Other products include TraySafe for medication replenishment and TubeSafe to prevent missing doses. Aethon's Intralogistics platform automates the movement of materials within healthcare facilities, improving operational efficiency and patient satisfaction. Founded in 1997 and based in Pittsburgh, Pennsylvania, Aethon was formerly known as Probotics Inc. and rebranded in 2001.

BodyMedia, founded in 1999 and based in Pittsburgh, PA, specializes in wearable body monitoring devices that gather physiological data to enhance health, wellness, and fitness. The company offers a range of continuous on-body monitors that utilize proprietary technology validated for clinical accuracy. These devices serve both consumers and health professionals, facilitating behavioral adjustments aimed at weight management and active living—critical factors in addressing serious health issues. BodyMedia's products include a calorie management system that tracks calories burned against those consumed, alongside body monitoring systems that record various physiological metrics analyzed through its SenseWear software. The company has contributed significantly to health research, participating in over 100 clinical studies related to obesity, diabetes, and other medical conditions, thereby creating one of the largest databases of human physiological information.

Renal Solutions is a company based in Warrendale, Pennsylvania, that specializes in the development of dialysis products and services. Founded in 2000 and acquired by Fresenius Medical Care in 2007, the company focuses on creating integrated medical devices for sorbent hemodialysis treatment. These devices provide a clinical care model tailored for patients with chronic and acute kidney failure, allowing healthcare practitioners to offer flexible and convenient treatment options. Renal Solutions aims to enhance renal care through innovative sorbent-based dialysis technologies.

Helomics Corporation, established in 1995 and headquartered in Pittsburgh, Pennsylvania, is a personalized healthcare company specializing in cancer care. It develops and delivers a portfolio of products to aid physicians and patients in making informed clinical decisions. Helomics' core technology, the Precision Cellular Analytical Platform, collects and analyzes cell cycle and proliferation data over an extended period. Key products include ChemoFx, BioSpeciFx, GeneFx Colon, and GeneFx Lung, which help physicians select effective treatments and understand potential drug responses or prognosis. The company also offers tumor profiling services, contract research and development, and biorepository and banking services. Helomics operates as a contract research organization (CRO), providing oncology insights for six primary cancers and using artificial intelligence and its D-CHIP platform to create personalized oncology roadmaps. It serves the pharmaceutical, diagnostic, biotechnology, and research industries, aiming to improve patient outcomes through personalized treatments and diagnostics.

BodyMedia, founded in 1999 and based in Pittsburgh, PA, specializes in wearable body monitoring devices that gather physiological data to enhance health, wellness, and fitness. The company offers a range of continuous on-body monitors that utilize proprietary technology validated for clinical accuracy. These devices serve both consumers and health professionals, facilitating behavioral adjustments aimed at weight management and active living—critical factors in addressing serious health issues. BodyMedia's products include a calorie management system that tracks calories burned against those consumed, alongside body monitoring systems that record various physiological metrics analyzed through its SenseWear software. The company has contributed significantly to health research, participating in over 100 clinical studies related to obesity, diabetes, and other medical conditions, thereby creating one of the largest databases of human physiological information.

Renal Solutions is a company based in Warrendale, Pennsylvania, that specializes in the development of dialysis products and services. Founded in 2000 and acquired by Fresenius Medical Care in 2007, the company focuses on creating integrated medical devices for sorbent hemodialysis treatment. These devices provide a clinical care model tailored for patients with chronic and acute kidney failure, allowing healthcare practitioners to offer flexible and convenient treatment options. Renal Solutions aims to enhance renal care through innovative sorbent-based dialysis technologies.

Helomics Corporation, established in 1995 and headquartered in Pittsburgh, Pennsylvania, is a personalized healthcare company specializing in cancer care. It develops and delivers a portfolio of products to aid physicians and patients in making informed clinical decisions. Helomics' core technology, the Precision Cellular Analytical Platform, collects and analyzes cell cycle and proliferation data over an extended period. Key products include ChemoFx, BioSpeciFx, GeneFx Colon, and GeneFx Lung, which help physicians select effective treatments and understand potential drug responses or prognosis. The company also offers tumor profiling services, contract research and development, and biorepository and banking services. Helomics operates as a contract research organization (CRO), providing oncology insights for six primary cancers and using artificial intelligence and its D-CHIP platform to create personalized oncology roadmaps. It serves the pharmaceutical, diagnostic, biotechnology, and research industries, aiming to improve patient outcomes through personalized treatments and diagnostics.

Helomics Corporation, established in 1995 and headquartered in Pittsburgh, Pennsylvania, is a personalized healthcare company specializing in cancer care. It develops and delivers a portfolio of products to aid physicians and patients in making informed clinical decisions. Helomics' core technology, the Precision Cellular Analytical Platform, collects and analyzes cell cycle and proliferation data over an extended period. Key products include ChemoFx, BioSpeciFx, GeneFx Colon, and GeneFx Lung, which help physicians select effective treatments and understand potential drug responses or prognosis. The company also offers tumor profiling services, contract research and development, and biorepository and banking services. Helomics operates as a contract research organization (CRO), providing oncology insights for six primary cancers and using artificial intelligence and its D-CHIP platform to create personalized oncology roadmaps. It serves the pharmaceutical, diagnostic, biotechnology, and research industries, aiming to improve patient outcomes through personalized treatments and diagnostics.

BodyMedia, founded in 1999 and based in Pittsburgh, PA, specializes in wearable body monitoring devices that gather physiological data to enhance health, wellness, and fitness. The company offers a range of continuous on-body monitors that utilize proprietary technology validated for clinical accuracy. These devices serve both consumers and health professionals, facilitating behavioral adjustments aimed at weight management and active living—critical factors in addressing serious health issues. BodyMedia's products include a calorie management system that tracks calories burned against those consumed, alongside body monitoring systems that record various physiological metrics analyzed through its SenseWear software. The company has contributed significantly to health research, participating in over 100 clinical studies related to obesity, diabetes, and other medical conditions, thereby creating one of the largest databases of human physiological information.

OnlineChoice is a Pittsburgh-based company founded in August 1999 that leverages the power of group buying to help consumers save on various goods and services, including electricity, natural gas, and communication services. By utilizing an online platform, OnlineChoice enables suppliers to market their offerings to large groups of consumers, thereby reducing their marketing costs. This collective purchasing model allows customers to access better prices and deals, making it an effective solution for those seeking to lower their expenses on essential services.